Cas:160347-94-4 Fmoc-D-Arg(NO2)-OH manufacturer & supplier

Chemical Name:Fmoc-D-Arg(NO2)-OH

CAS.NO:160347-94-4

Synonyms:Nalpha-Fmoc-Nomega-nitro-L-arginine;fmoc-nw-nitro-d-arginine;Fmoc-D-Arg(NO2)-OH;D-Ornithine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[imino(nitroamino)methyl]-;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-(N-nitrocarbamimidoyl)-D-ornithine;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-(1-nitrocarbamimidamido)pentanoic acid

Molecular Formula:C₂₁H₂₃N₅O₆

Molecular Weight:441.437

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.5±0.1 g/cm3

Index of Refraction:1.674

PSA:169.36000

Exact Mass:441.164825

LogP:3.44

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Nalpha-Fmoc-Nomega-nitro-L-arginine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-(1-nitrocarbamimidamido)pentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,fmoc-nw-nitro-d-arginine Use and application,fmoc-nw-nitro-d-arginine technical grade,usp/ep/jp grade.

Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. Fmoc-D-Arg(NO2)-OH manufacturer Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. Fmoc-D-Arg(NO2)-OH supplier Italy and Vietnam included Taiwan in banning flights from China, a move that they announced after the W.H.O. declared the coronavirus outbreak a global health emergency. Fmoc-D-Arg(NO2)-OH vendor Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. Fmoc-D-Arg(NO2)-OH factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.